BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8161198)

  • 1. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol.
    Leonard DA; Kotarski MA; Tessiatore JE; Favata MF; Trzaskos JM
    Arch Biochem Biophys; 1994 Apr; 310(1):152-7. PubMed ID: 8161198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Anderson JA; Leonard DA; Cusack KP; Frye LL
    Arch Biochem Biophys; 1995 Jan; 316(1):190-6. PubMed ID: 7840615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.
    Trzaskos JM; Magolda RL; Favata MF; Fischer RT; Johnson PR; Chen HW; Ko SS; Leonard DA; Gaylor JL
    J Biol Chem; 1993 Oct; 268(30):22591-9. PubMed ID: 7693673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Leonard DA
    Crit Rev Biochem Mol Biol; 1999; 34(2):123-40. PubMed ID: 10333389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of hepatic lanosterol 14 alpha-demethylase gene expression by dietary cholesterol and cholesterol-lowering agents.
    Ness GC; Gertz KR; Holland RC
    Arch Biochem Biophys; 2001 Nov; 395(2):233-8. PubMed ID: 11697861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ
    Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 19-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and lanosterol demethylase activity.
    Sonoda Y; Suzuki S; Udagawa K; Ota K; Tasaka R; Fukamachi Y; Sato Y
    Biol Pharm Bull; 1996 Jan; 19(1):57-61. PubMed ID: 8820912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxolanosterol oximes: dual-action inhibitors of cholesterol biosynthesis.
    Frye LL; Cusack KP; Leonard DA; Anderson JA
    J Lipid Res; 1994 Aug; 35(8):1333-44. PubMed ID: 7989858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of transcription, translation, and protein turnover in controlling the distribution of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the lens.
    Cenedella RJ
    Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):2133-41. PubMed ID: 7544784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
    Iglesias J; Gibbons GF
    Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ accumulation of 3 beta-hydroxylanost-8-en-32-aldehyde in hepatocyte cultures. A putative regulator of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity.
    Trzaskos JM; Favata MF; Fischer RT; Stam SH
    J Biol Chem; 1987 Sep; 262(25):12261-8. PubMed ID: 3624256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The length of 5'-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate.
    Gayen AK; Peffley DM
    Arch Biochem Biophys; 1995 Oct; 322(2):475-85. PubMed ID: 7574724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proto oncogene/eukaryotic translation initiation factor (eIF) 4E attenuates mevalonate-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase synthesis.
    Buechler RD; Peffley DM
    Mol Carcinog; 2004 Sep; 41(1):39-53. PubMed ID: 15352124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells.
    Mayer RJ; Adams JL; Bossard MJ; Berkhout TA
    J Biol Chem; 1991 Oct; 266(30):20070-8. PubMed ID: 1657912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels and synthesis in syrian hamster C100 cells by the oxidosqualene cyclase inhibitor [4'-(6-allyl-ethyl-amino-hexyloxy)-2'-fluoro-phenyl]-(4-bromophenyl)-me thanone (Ro 48-8071): comparison to simvastatin.
    Peffley DM; Gayen AK; Morand OH
    Biochem Pharmacol; 1998 Aug; 56(4):439-49. PubMed ID: 9763219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Obi N; Onoda M; Sakakibara Y; Sato Y
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2796-9. PubMed ID: 1464112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 24(S),25-oxidolanosterol.
    Panini SR; Delate TA; Sinensky M
    J Biol Chem; 1992 Jun; 267(18):12647-54. PubMed ID: 1618770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by azole antimycotics requires lanosterol demethylation, but not 24,25-epoxylanosterol formation.
    Favata MF; Trzaskos JM; Chen HW; Fischer RT; Greenberg RS
    J Biol Chem; 1987 Sep; 262(25):12254-60. PubMed ID: 3624255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.